The protein medin builds up in the blood vessels of Alzheimer’s patients’ brains together with the protein amyloid. Researchers from the DZNE team discovered this co-aggregation. Their discovery has since been made public in the esteemed magazine Nature. "Although Medin has been around for more than 20 years, its impact on illnesses was previously underrated. We were able to demonstrate that medin considerably increases the pathological changes in the blood vessels of Alzheimer’s patients "explained Dr Jonas Neher, the study’s principal investigator and director of the DZNE’s Tubingen location.
About the Author
